DBV Technologies S.A. - American Depositary Shares — 현금 흐름 (NASDAQ:DBVT) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

영업활동으로 인한 현금 -165.61 M-108.24 M-55.67 M-79.65 M-104.47 M-121.18 M -150.58 M 투자 활동으로 인한 현금 -2.87 M-433 K-100 K-808 K-757 K-1.37 M -1.27 M 재무활동으로 인한 현금 149.55 M274 K194.12 M6.77 M587 K276.18 M 365.08 M 잉여 현금 흐름 -165.61 M-108.24 M-55.67 M-79.65 M-104.47 M-121.18 M -150.58 M

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

뉴스

Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?

DBV Technologies: A Cohort-Driven Model That Could Support Blockbuster VIASKIN Revenue

DBV Technologies (DBVT) Upgraded to Buy: What Does It Mean for the Stock?

Wall Street Analysts Predict a 79.04% Upside in DBV Technologies (DBVT): Here's What You Should Know

DBV Technologies: A Tough Nut To Crack In A Shrinking Market (NASDAQ:DBVT)

DBV 테크놀로지, Viaskin Peanut 잠재력에 시티즌스 투자의견 재확인

Citizens reiterates DBV Technologies stock rating on Viaskin Peanut potential

DBV Technologies, 긍정적 임상시험 결과에 주가 급등

DBV Technologies stock surges on new peanut patch trial data

DBV테크놀로지, Guggenheim, ’매수’ 등급 재확인… 목표가 $51

Guggenheim reiterates Buy rating on DBV Technologies stock with $51 target

Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Ambarella (NASDAQ:AMBA), AST SpaceMobile (NASDAQ:ASTS)